Wells Fargo
DSGN icon

Wells Fargo’s Design Therapeutics DSGN Stock Holding History

Wells Fargo’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96K Sell
9,027
-17,759
-66% -$180K ﹤0.01% 5123
2025
Q4 		$251K Buy
26,786
+8,469
+46% +$66.3K ﹤0.01% 4938
2025
Q3 		$138K Sell
18,317
-1,967
-10% -$9.85K ﹤0.01% 5143
2025
Q2 		$68.4K Buy
20,284
+1,438
+8% +$5.38K ﹤0.01% 5399
2025
Q1 		$72.7K Buy
18,846
+418
+2% +$1.99K ﹤0.01% 5255
2024
Q4 		$114K Buy
18,428
+4,013
+28% +$23.2K ﹤0.01% 5131
2024
Q3 		$77.6K Buy
14,415
+618
+4% +$2.91K ﹤0.01% 5159
2024
Q2 		$46.2K Buy
13,797
+2,291
+20% +$8.93K ﹤0.01% 5323
2024
Q1 		$46.4K Buy
11,506
+1,484
+15% +$3.96K ﹤0.01% 5283
2023
Q4 		$26.6K Buy
10,022
+1,990
+25% +$4.56K ﹤0.01% 5533
2023
Q3 		$19K Sell
8,032
-4,431
-36% -$20.7K ﹤0.01% 5622
2023
Q2 		$78.5K Buy
12,463
+6,469
+108% +$39.6K ﹤0.01% 5180
2023
Q1 		$34.6K Buy
+5,994
New +$44.8K ﹤0.01% 5368
2022
Q4 		– Sell
-406
Closed -$7K – 7518
2022
Q3 		$7K Sell
406
-30
-7% -$597 ﹤0.01% 5805
2022
Q2 		$6K Sell
436
-217
-33% -$2.93K ﹤0.01% 5939
2022
Q1 		$10K Sell
653
-9,290
-93% -$142K ﹤0.01% 6259
2021
Q4 		$213K Buy
+9,943
New +$171K ﹤0.01% 5226

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wells Fargo's DSGN Position: Q1 2026 in Review

Wells Fargo reduced its Design Therapeutics (DSGN) stake by 66% in Q1 2026, selling an estimated $180K and leaving 9,027 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #5123.

Wells Fargo first reported a position in DSGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $251K in Q4 2025. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Wells Fargo held 9,027 shares of Design Therapeutics worth $96K as of Q1 2026.
  • Wells Fargo sold 17,759 Design Therapeutics shares in Q1 2026, an estimated $180K.
  • Design Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5123 holding.
  • Wells Fargo first reported a position in Design Therapeutics in Q4 2021 and has held it in 17 quarters since.
  • Wells Fargo's Design Therapeutics position peaked at $251K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.